BTMD biote Corp.

NAS · US · Healthcare · Medical Care Facilities · biote.com

1.110USD-2.63%Mkt Cap: 37.63M $P/E: 7.931d ago

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men …

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$26.50BUSDP/E 15.6

THC

Tenet Healthcare Corporation

$20.92BUSDP/E 10.1

EHC

Encompass Health Corporation

Fresenius Medical Care AG

$10.92BUSDP/E 11.3

FMS

Fresenius Medical Care AG

$11.01BUSDP/E 10.7

UHS

Universal Health Services, Inc.

$10.29BUSDP/E 7.1

ENSG

The Ensign Group, Inc.

Option Care Health, Inc.

$4.65BUSDP/E 23.5

CON

Concentra Group Holdings Parent, Inc.

$4.64BUSDP/E 23.5

LFST

LifeStance Health Group, Inc.

National HealthCare Corporation

$3.46BUSDP/E 24.9

ACHC

Acadia Healthcare Company, Inc.

$2.72BUSD

AVAH

Aveanna Healthcare Holdings Inc.

$2.69BUSDP/E 9.8

GRDN

Guardian Pharmacy Services, Inc.

$2.58BUSDP/E 39.5

BKD

Brookdale Senior Living Inc.

$2.57BUSD

Key Statistics

Company

Market Cap37.63M USD

Enterprise Value157.76M USD

Revenue (TTM)183.53M USD

Gross Profit137.36M USD

Net Income (TTM)27.05M USD

Revenue/Share6.05 USD

Last Price1.110 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees223

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)7.93

P/E (Forward)2.53

PEG—

EV/EBITDA6.19

EV/Revenue0.86

P/S0.21

P/B-0.48

EPS (TTM)0.14

EPS (Forward)0.45

52W Range

1.0851% of range3.260

52W High3.260 USD

52W Low1.085 USD

Profitability

Gross Margin71.46%

Oper. Margin5.29%

EBITDA Margin13.88%

Profit Margin14.07%

ROE-46.20%

ROA25.13%

Growth

Revenue Growth-9.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF35.19M USD

CapEx (TTM)6.86M USD

FCF Margin-2.72%

FCF Yield-13.27%

Net Debt117.47M USD

Net Debt/EBITDA4.61

Balance Sheet

Debt/Equity-1.88

Current Ratio1.43

Quick Ratio0.69

Book Value/Sh-2.38 USD

Cash/Share0.39 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)2.612 USD

Upside (mean)+135.3%

Target Range1.500 USD – 4.000 USD

1.500+135.3% to mean4.000

# Analysts5

Ownership

Shares Out.28.68M

Float16.47M

Insiders19.82%

Institutions62.97%

Short Interest

Short Ratio3.8d

Short % Float6.30%

Short % Out.4.47%

Shares Short1.28M

Short (prev mo.)658.98K

Technical

SMA 501.551 (-28.4%)

SMA 2001.969 (-43.6%)

Beta1.69

S&P 52W Chg16.45%

Avg Vol (30d)161.22K

Avg Vol (10d)113.86K

Technical Indicators

RSI (14)28.3

MACD-0.1341

MACD Signal-0.1368

MACD Hist.+0.0027

BB Upper1.501 USD

BB Middle1.275 USD

BB Lower1.049 USD

BB Width35.41%

ATR (14)0.0976 USD

Vol Ratio (20d)1.67x